Header imageLink to The BSE Inquiry Home pageLink to Key to footnotesLink to Who's Who sectionLink to Glossary sectionLink to Chronology sectionLink to HelpLink to Search page
<<Previous | Next>>
Volume Specific - Glossary | Who's Who
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Volume 7: Medicines and Cosmetics
Index

Return to top of page

S

safety of medicines
saliva  2
salivary glands
saponification
SARS see Suspected Adverse Reactions Scheme
sausage casings  2,  3
SBO see Specified Bovine Offal
scalpel blades, disposable  2,  3,  4
SCC see Scientific Committee on Cosmetology
Schild, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12
science-based judgements
Scientific Committee on Cosmetology (SCC)  2,  3,  4
Scientific Committee on Cosmetology (SCC), advice on BSE and cosmetics
Scientific Secretariat
Scientific Veterinary Committee on Spongiform Encephalopathies
Scollen, Mr  2,  3,  4,  5
Scotland  2,  3
scrapie  2,  3,  4,  5,  6,  7,  8,  9
scrapie, causative agents
scrapie, implications for human health
scrapie, in foetal lambs
scrapie, lack of evidence for transmission to humans  2
scrapie, lack of similarity to CJD
scrapie, serum from infected animals
scrapie, tissue distribution of infectivity
scrapie, transmission in secretions and excretions
scrapie, vertical transmission
scrapie-like agents  2
scrapie-like agents, inactivation of  2,  3,  4,  5,  6,  7
SEAC see Spongiform Encephalopathy Advisory Committee
SEAR  2
Secretary of State  2,  3
Secretary of State for Health  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14
Secretary of State for Health, licences held by  2
secretions, isolation of scrapie from
section 4 committees  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13
section 4 committees, flow of information between
section 4 committees, role of
section 4 committees, use as advisers
semen  2
Senior Medical Officer (SMO)  2,  3,  4,  5
Senior Principal Medical Officer (SPMO)  2
Senior Principal Pharmaceutical Officer
Serum and Glandular Products Order
serum and serum products  2,  3,  4
serum, as poor source of infectivity
serum, preparation of  2,  3
Shannon, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10
shaving sticks
sheep  2,  3,  4,  5,  6,  7,  8,  9
sheep brain
sheep, feeding of sheep material to cattle
sheep, offal
sheep, scrapie-infected, protein derived from
shepherds, scrapie not transmitted to
Shersby, Mrs  2,  3,  4,  5,  6,  7,  8,  9
Shreeve, Dr
Simpson, Dr
Singh, Dr  2,  3,  4
single use sterile devices
SKF  2,  3
skin creams
skin see topical medicinal products
skull
skull, in gelatin manufacture
slaughterhouse workers, scrapie not transmitted to
slaughterhouses  2,  3,  4,  5,  6
slaughterhouses, bovine ingredients as by-product of
slaughterhouses, cross-contamination in
slaughterman
Sloggem, Mr John  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20
Sloggem, Mr John, CSM/BSC discussion of paper  2
slow virus syndrome  2,  3,  4,  5
Smith, Mr
SmithKline Beecham  2
SMO see Senior Medical Officer
soaps  2
sodium hydroxide disinfection
Soul, Mr
Southwood Report  2
Southwood Report  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19
Southwood Report, as 'damp squib'  2
Southwood Report, discusion with Ministers
Southwood Report, message of
Southwood Working Party  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29,  30,  31,  32
Southwood Working Party, consideration of guidelines
Southwood Working Party, discussion of biological products
Southwood Working Party, risk assessment
Southwood, Sir Richard  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17
Southwood, Sir Richard, correspondence with
Southwood, Sir Richard, letter to CSM
Special Health Authority
specific pathogen free (SPF) herds
Specified Bovine Offal (SBO)  2
Specified Bovine Offal (SBO), unstained and unsterilised
Specified Bovine Offal ban  2,  3
Specified Bovine Offal ban, exemptions from  2,  3,  4,  5
Specified Bovine Offal ban, further consideration of tissues covered by
Specified Bovine Offal ban, implications for medical devices
Specified Bovine Offal ban, implications for medicinal products
Specified Bovine Offal ban, inconsistency with BSEWG advice
Specified Bovine Offal ban, public consultation
sperm
SPF see specific pathogen free herds
spinal cord  2,  3,  4,  5,  6,  7,  8,  9,  10,  11
spinal cord, in gelatine manufacture
spinal cord, infectivity of
spine, in gelatine manufacture
spleen  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19
spleen, infectivity of
spleen, pharmaceutical use
SPMO see Senior Principal Medical Officer
Spongiform Encephalopathy Advisory Committee (SEAC)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16
Spongiform Encephalopathy Advisory Committee (SEAC), consideration of Tyrrell proposal A1d
Spongiform Encephalopathy Advisory Committee (SEAC), eighth meeting
Spongiform Encephalopathy Advisory Committee (SEAC), first meeting
Spongiform Encephalopathy Advisory Committee (SEAC), Interim Report on Research
Spongiform Encephalopathy Advisory Committee (SEAC), ninth meeting
Spongiform Encephalopathy Advisory Committee (SEAC), note on non-food preparations
Spongiform Encephalopathy Advisory Committee (SEAC), perceptions of
Spongiform Encephalopathy Advisory Committee (SEAC), relevance of pharmaceutical research
Spongiform Encephalopathy Advisory Group (SEAC), fourth meeting
Sprang, Dr
staff, recruitment and retention
staining
State Veterinary Service (SVS)
STD see Supplies Technology Division
stearic acid  2
Stelchens, Mr
sterilisation  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16
Stewart, Mr
stick deodorants
subclinically infected cattle
suckler herds
Supplies Technology Division (STD)  2,  3,  4,  5,  6,  7,  8
Supplies Technology Division (STD), comments of Tyrrell Report
Supplies Technology Division (STD), responsibility for follow-up of guidelines
surgical catgut see catgut
surgical ligatures
surgical materials  2
Surgical Materials Order SI 1971 No. 1276
Suspected Adverse Reactions Scheme (SARS)  2
Sutton, Dr
sutures  2,  3,  4,  5,  6,  7
sutures, absorbable
sutures, from French sources
sutures, production of
SVS see State Veterinary Service
Switzerland  2,  3,  4
Switzerland, BSE in  2,  3
syringes, disposable  2,  3,  4
Return to top of page

T

tail  2
tallow  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21
tankage
tanners  2
Taylor, Dr David  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13
Taylor, Mr  2,  3,  4
Taylor, Mr A J C  2
Taylor, Mr Alan
Taylor, Mr David
Taylor, Mr Kevin
Taylor, Professor Ken
tendons  2
tetanus vaccine  2
Thompson, Mr
Thornton, Dr Denise  2
thymus  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18
thyroid gland  2
tissue, products derived from
toiletries see cosmetics
Tolworth see Animal Medicines Division
tongue  2
tonsils  2,  3,  4,  5,  6
tonsils, infectivity of
topical cosmetic products
topical medicinal products  2,  3,  4,  5,  6,  7
topical medicinal products, exemption from guidelines
Townsend, Mrs Stephanie  2
trachea  2
trading
trading standards department
transesterification
transmissible spongiform encephalopathies (TSE)  2,  3,  4
transmissible spongiform encephalopathies (TSE), consideration by WHO
transmissible spongiform encephalopathies (TSE), in cat  2
transmissible spongiform encephalopathies (TSE), species barrier
tripe  2
TSE see transmissible spongiform encephalopathies
Tuberculin PPD vaccine  2,  3,  4,  5
Turner, Mr  2
Tyrrell Committee  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20
Tyrrell Committee, discussions of
Tyrrell Committee, funding of
Tyrrell Committee, interim report
Tyrrell Committee, progress on recommendations
Tyrrell Committee, proposals C2a and C2b  2,  3,  4,  5
Tyrrell Committee, recommendation A1d
Tyrrell Committee, response of
Tyrrell Report  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12
Tyrrell Report, comments from STD
Tyrrell Report, proposals C2a and C2b
Tyrrell Report, publication of
Tyrrell, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12
Tyrrell, Dr, concerns about gelatine
Return to top of page

U

udders  2,  3
Under Secretary for Animal Health
unfit meat
Unilever
Unipath
unlicensed products
urine
uterus  2
Return to top of page

V

vaccination programme  2,  3,  4
vaccination programme, dangers of interrupting
vaccination programme, importance of
vaccination programme, potential risks of
vaccine scare  2,  3,  4,  5,  6
vaccines  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13
vaccines, animal  2,  3
vaccines, as possible source of BSE
vaccines, availability of supply
vaccines, Bovulin
vaccines, children's  2,  3
vaccines, clean stocks of
vaccines, diphtheria
vaccines, DTP  2,  3,  4,  5,  6
vaccines, existing stocks of  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12
vaccines, fish  2
vaccines, heat treatment of
vaccines, human
vaccines, louping-ill
vaccines, lungworm  2
vaccines, measles  2,  3,  4,  5
vaccines, MMR  2,  3,  4,  5
vaccines, not complying with CSM/VPC guidelines  2,  3
vaccines, preparation using bovine material  2,  3,  4,  5,  6,  7,  8,  9
vaccines, rabies  2
vaccines, rubella
vaccines, storage
vaccines, tetanus
vaccines, Tuberculin PPD  2,  3,  4,  5
vaccines, whooping cough
vascular prostheses
vasopressin
veal
veterinary medicines  2,  3,  4,  5,  6,  7,  8,  9
Veterinary Medicines Directorate (VMD)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14
Veterinary Medicines Directorate (VMD), adequacy of response
Veterinary Medicines Directorate (VMD), audit of manufacturers
Veterinary Medicines Directorate (VMD), biologicals and recombinant products team
Veterinary Medicines Directorate (VMD), changing Directorship of
Veterinary Medicines Directorate (VMD), feed additives team
Veterinary Medicines Directorate (VMD), follow-up of guidelines by  2
Veterinary Medicines Directorate (VMD), pharmaceuticals team
Veterinary Medicines Directorate (VMD), progress report from MCA
Veterinary Medicines Directorate (VMD), report to VPC  2
veterinary medicines, audit of
veterinary medicines, consideration by BSE Working Group
veterinary medicines, Cunliffe Report  2
veterinary medicines, follow-up of guidelines
veterinary medicines, licensing  2
veterinary medicines, not complying with CSM/VPC guidelines
veterinary medicines, progress report
veterinary medicines, response on  2
veterinary medicines, response to CSM/VPC guidelines
veterinary medicines, update on responses to questionnaire
Veterinary Products Committee (VPC)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24
Veterinary Products Committee (VPC), agreement to guidelines
Veterinary Products Committee (VPC), approval of guidelines
Veterinary Products Committee (VPC), discussion of draft guidelines
Veterinary Products Committee (VPC), joint CSM/VPC guidelines  2,  3
Veterinary Products Committee (VPC), report from VMD  2
Veterinary Products Committee (VPC), responsibility for follow-up of guidelines
Veterinary Products Committee (VPC), responsibility for veterinary product safety
veterinary surgeons
veterinary surgeons, scrapie not transmitted to
Viral Products Advisory Panel, NIBSC
viruses  2
viruses, hardy  2
viruses, heat resistance of
vitamin supplements
VMD see Veterinary Medicines Directorate
VPC see Veterinary Products Committee
Return to top of page

W

Wales  2,  3
Walker, Mr John  2,  3
waste
Watson, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15
Weleda
Wellcome Biotechnology  2,  3,  4,  5,  6
Wellcome Biotechnology, response to questionnaire
Wellcome Biotechnology, studies with NIBSC
Wellcome Foundation
Wellcome Laboratories
Wells, Mr  2
Weybridge see Central Veterinary Laboratory
Whitbread, Mr L  2
White, Dr Ian
WHO see World Health Organisation
whooping cough vaccine  2
Whyte, Mrs Diane  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15
Wight, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19
Wilesmith, Mr John  2,  3,  4,  5,  6,  7
Wilkes, Mr  2
Will, Dr  2,  3
Wills, Dr
Wilson, Mr Clive  2,  3,  4,  5,  6,  7,  8
Winship, Dr  2,  3,  4,  5,  6,  7
Wood, Dr Susan  2,  3,  4,  5,  6
Wood, Mr Geoff  2,  3,  4,  5,  6,  7
Woodward, Dr KN
Woolley, Mr Derek  2
Working Party on BSE see Southwood Working Party
World Health Organisation (WHO)
World Health Organisation (WHO), consideration of TSE
wound dressings  2,  3
wounds, topical preparations  2,  3,  4,  5
Return to top of page

X

Return to top of page

Y

Yellow Card Scheme  2
Yellow Card Scheme, veterinary
Return to top of page

Z

Zeneca
<<Previous | Next>>
Return to top of page


© Crown Copyright 2000. Legal notice.
Any part of this report may be reproduced subject to acknowledgement.
The Inquiry Report | Findings & conclusions | Download report as PDF | Evidence | Contact details | Order a copy | Glossary | Chronology | Who's who | Key to footnotes | Help | Search